rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2007-1-8
|
pubmed:abstractText |
Atopic dermatitis (AD) is an immunological skin disease. It is common in pediatric populations and often requires topical steroid treatment. Moderate to severe AD may not respond to topical steroids. They often require systemic steroids, which may result in growth retardation. Protopic, a non-steroid, tacrolimus based ointment which is a calcinurin inhibitor has been proved to be effective in caucacian with AD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0125-2208
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1915-22
|
pubmed:meshHeading |
pubmed-meshheading:17205874-Administration, Topical,
pubmed-meshheading:17205874-Child,
pubmed-meshheading:17205874-Dermatitis, Atopic,
pubmed-meshheading:17205874-Female,
pubmed-meshheading:17205874-Humans,
pubmed-meshheading:17205874-Immunosuppressive Agents,
pubmed-meshheading:17205874-Male,
pubmed-meshheading:17205874-Ointments,
pubmed-meshheading:17205874-Quality of Life,
pubmed-meshheading:17205874-Severity of Illness Index,
pubmed-meshheading:17205874-Tacrolimus,
pubmed-meshheading:17205874-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
|
pubmed:affiliation |
Dermatology Unit, Queen Sirikit National Institute of Child Health, Bangkok 10400, Thailand.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|